3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia
1
Interventions
venetoclax
4
Cyclophosphamide
4
fludarabine
3
Azacitidine
3
blinatumomab
2
Whole-Body Irradiation
2
Cytarabine
2
Blood Specimen Collection
2
pegaspargase
1
etoposide phosphate
1
capivasertib
1
Vincristine
1
Tretinoin
1
Tissue Banks
1
Tacrolimus
1
Mycophenolic Acid
1
Methotrexate
1
Mercaptopurine
1
Immunotherapy, Adoptive
1
IPI-549
1
Etoposide
1
Drug Therapy, Combination
1
Doxorubicin
1
Dexamethasone
1
Decitabine
1
Calcium Dobesilate
1
Busulfan
1
Arsenic Trioxide
1
Anthracyclines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Leukemia
×
IPI-549
×
Clear all
NCT07439211
2026-03-03
GAVEL
Dana-Farber Cancer Institute
Phase 1
Not yet recruiting
48 enrolled